StockWatch
·

NATIONAL PEROXIDE LTD. Q2 FY27 Results

NAPEROLQ2 FY27 Results
Filing
Result:Steady· Market: Flat#Turnaround#Base effect#Margin expansion
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue3.9358.5%33.7%
Total Income3.9258.8%33.4%
Expenditure3.4662.6%19.5%
PBT0.4687.9%1007.7%
Net Profit0.40119.8%3960.6%
OPM11.81%9.93pp10.51pp
NPM10.23%8.31pp10.58pp
EPS0.70118.8%3400.0%
View full financials

A loss-to-profit turnaround and expanding margins are more than offset by a tiny base (₹0.01 Cr prior-year loss), revenue down 58% QoQ, and profit driven by passive investment/trading-segment swings rather than any recurring operating business.

Q2 FY-2027 RESULTS · NAPEROL

Naperol Investments turns profitable at ₹0.40 Cr PAT, margins expand sharply y/y

revenue +33.7% · margins expanding

11 Nov 2026 · 3 min read
Revenue

₹3.93 Cr

+33.7% YoY

PAT (standalone)

₹0.4 Cr

Net margin

10.23%

+10.6pp YoY

EPS

₹0.7

Naperol Investments Limited (formerly National Peroxide Limited) — now operating purely as an investment-holding company after its hydrogen-peroxide manufacturing business was demerged into separately listed National Peroxide Ltd — posted a standalone net profit of ₹0.40 Cr for Q2 FY27, a turnaround from a ₹0.01 Cr loss a year ago. Revenue from operations rose 34% YoY to ₹3.93 Cr but fell 58% QoQ from ₹9.45 Cr in Q1 FY27, since almost all of the topline is Trading-segment churn from buying/selling securities rather than a recurring operating business. There were no exceptional items in either the current or year-ago quarter, so the YoY swing to profit is the clean, as-reported number — no raw-vs-adjusted distinction is needed here.

The scoreboard

Q2 FY-2027 vs prior quarters

Standalone P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹3.93 Cr-58.5%+33.7%
Expenses₹3.46 Cr-62.6%+19.5%
PAT₹0.4 Cr+119.8%—
Net margin10.23%+8.3pp+10.6pp
EPS₹0.7+118.7%+3400%

The improvement is a segment-mix story, not a scale story. The Investment segment — passive income (dividends, interest, FVTPL gains) off the company's ₹914 Cr investment book — generated ₹0.58 Cr of pre-tax profit this quarter, roughly 87% of the ₹0.66 Cr total segment result, while the Trading segment added just ₹0.08 Cr, down from ₹0.25 Cr in Q1 FY27 and versus a ₹0.02 Cr loss a year ago. Net margin (PAT/total income) expanded to ~10.2% from 1.92% in Q1 FY27 and -0.35% a year ago; operating margin (revenue less total expenses) widened to ~11.8% from 1.88% QoQ and ~1.3% YoY — both effects of this quarter's lower trading volumes needing proportionally lower stock-purchase costs, not any pricing or cost action.

₹
460.05532.39604.72677.06749.453508-1009-0109-2410-1911-11Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹535, down 6.1% over the past month of trading.

₹ Cr
-2.012.877.7512.630.08Q1 FY26rev ₹3 Cr-0.01Q2 FY26rev ₹3 Cr-0.59Q3 FY26rev ₹1 Cr11.22Q4 FY26rev ₹20 Cr0.18Q1 FY27rev ₹9 Cr0.4Q2 FY27rev ₹4 Cr
Quarterly standalone PAT, ₹ Crore

For context: this is the second-highest quarterly PAT of the last 6 quarters.

There is no management guidance on record and no prior concall read in our context to benchmark against — management gives no formal forward outlook — and a web search turned up no analyst or brokerage coverage of the stock, so the print cannot be checked against a street number; no company press release beyond the board-outcome letter was available for this quarter. The same November 11, 2026 board meeting that approved these results also appointed Mr. Vinay Divakar Jayade — currently CEO of group company National Peroxide Ltd — as an Additional Director, and Ms. Jinal Shah as Company Secretary, alongside a separate director's resignation on November 2, 2026; these are governance items unconnected to the quarter's numbers but consistent with ongoing board reconstitution post-demerger.

  • W1

    Trading segment pre-tax profit — ₹0.08 Cr this quarter vs ₹0.25 Cr in Q1 FY27 — whether it stabilizes above the ₹0.20 Cr level given its revenue volatility.

  • W2

    Investment segment pre-tax income, which has run ₹0.49–0.66 Cr per quarter over the trailing year; a sustained move outside that band would be the first sign of a shift in the ₹914 Cr portfolio's return profile.

  • W3

    Any capital-allocation signal from newly appointed Additional Director Mr. Vinay Jayade (effective Nov 11, 2026), given his operating-company background versus the board's current investment-holding mandate.

Informational and educational content only. Not investment advice.